Clostridium Difficile

FDA wants to fast-track treatments for C. diff

By

Clostridium difficile poses a serious public health threat and potential treatments should be fast-tracked, the Food and Drug Administration stated in a newly proposed regulation.

Probiotics reduce risk of C. diff symptoms by 64%, researchers say

By

Long-term care facilities dealing with an outbreak of Clostridium difficile have a good chance of reducing symptoms of the infection by administering probiotics, according to a recently released comprehensive review of randomized trials.

Depression tied to C. diff

Depression tied to C. diff By

Depressed or lonely people are at increased risk of Clostridium difficile infection, according to research in BMC Medicine.

Catching bad bugs

Catching bad bugs By

New strains of drug-resistant pathogens are targets of more scrutiny among infection control professionals employed in long-term care environments.

Fecal transplants to treat C. diff now need FDA approval

By

The Food and Drug Administration is moving to tighten regulations around fecal transplants, which research has shown to be an effective treatment for Clostridium difficile infection.

Depressed, lonely seniors are more likely to get C. diff, researchers find

By

People who are depressed or lonely are at increased risk of Clostridium difficile infection, according to recently published research.

Three risk factors could help uncover C. diff. carriers, researchers say

By

Long-term care providers might want to pay special attention to residents with certain recently identified risk factors for Clostridium difficile. These factors are chronic dialysis, recent hospitalization and use of corticosteroids such as prednisone.

CompanyBriefs

Pfizer must pay $142 million for the marketing and prescribing of epilepsy drug Neurontin for unapproved uses, a federal appeals court has ruled. The justices refused to overturn a jury's previous verdict. The jury determined Pfizer marketed Neurontin for bipolar disorder, migraines and neuropathic pain. The Food and Drug Administration had not approved the medicine for any of those uses.

Stomach acid drugs raise risk of C. diff

By

Stomach acid is often treated with medications such as Pepcid, but that could put long-term care residents or hospitalized patients at risk for Clostridium difficile, according to a new analysis.

C. diff especially deadly for those with kidney disease, researchers find

By

People with end-stage renal disease (ESRD) have a significantly elevated risk of dying from Clostridium difficile infection, according to a recent study.

Limiting use of common antihistamines could reduce C. diff in facilities, researchers say

By

Taking antihistamines such as Tagamet, Pepcid and Zantac increases the risk that people in healthcare settings will be infected with Clostridium difficile, according to a recently published study.

APIC updates its free guide to C. difficile prevention

APIC updates  its free guide to C. difficile prevention

The Association for Professionals in Infection Control and Epidemiology has issued an updated Clostridium difficile infections Implementation Guide.

Efforts to combat Clostridium difficile are coming up short, survey finds

By

Long-term care operators and other healthcare providers are having limited success in combating Clostridium difficile infections, despite increasing their efforts in the last three years, according to recently released survey results.

Taking steps to prevent Clostridium difficile infections

Taking steps to prevent Clostridium difficile infections

The numbers are in and they are grim. There are 165,000 cases, $1.3 billion in excess costs, and 9,000 deaths from Clostridium difficile infections that are healthcare-acquired in the United States annually.

'Fake stool' a possible aid for C. diff patients

By

A pair of Clostridium difficile patients were cured through introduction of a super-probiotic synthetic stool called RePOOPulate, leading researchers to express hope that the treatment can be adopted on a more widespread basis.

The tail of C. diff: Dog can detect illness with accuracy, researchers say

The tail of C. diff: Dog can detect illness with accuracy, researchers say By

Finally, some good news about a Cliff. After two months of training, a two-year-old beagle named Cliff demonstrated success at being able to detect C. diff in stool samples in a lab environment, researchers in Netherlands have discovered.

Healthcare's dirty secret

Healthcare's dirty secret By

If there's one topic where I feel that healthcare publications tend to repeat themselves, it's around infection control.

Bacteria mix offers hope for those with C. diff

By

Researchers have hit on a potentially novel way to fight Clostridium difficile: a cocktail of six different types of bacteria.

Study reveals that ultraviolet light eliminates deadly hospital-acquired infections

By

Researchers say they nearly eliminated deadly antibiotic-resistant bacteria in a study encompassing 50 patient rooms at two medical facilities by using a specific spectrum of ultraviolet light.

New tracking tools, guidance help nursing homes treat and prevent facility-acquired infections

By

Government health officials have released a tracking tool that can help nursing homes monitor healthcare-acquired infections.

September 11 death count, times 10

September 11 death count, times 10 By

Many people shudder when they think about the 9/11 tragedy, and rightfully so. The four suicide attacks carried out on September 11 of 2001 caused nearly 3,000 deaths. But imagine if there were 10 such attacks every year and 30,000 people died. Actually, 30,000 people DO die every year, thanks to a silent killer most people have never heard of.

Some individuals pre-disposed to recurrent c. diff infections

By

Some individuals are predisposed — either genetically or due to an underlying inflammatory condition — to recurrent Clostridium difficile infections, new research finds.

HHS healthcare-associated infection reduction plan is open for public comments

By

The Department of Health and Human Services is seeking public comments on its updated action plan — which includes efforts in nursing homes — to reduce or eliminate healthcare-associated infections.

Nursing home residents more likely to die from C. diff infections, research suggests

Nursing home residents more likely to die from C. diff infections, research suggests

Living at a nursing home may be a predictor of whether a hospital patient dies from Clostridium difficile, a new study suggests.

Antacids linked with higher mortality rates in c. diff patients, study finds

People infected with Clostridium difficile were five times more likely to die if they had recently taken stomach acid medications, a new study revealed.

Experimental drug is helpful against c. diff, animal study finds

An experimental compound, which investigators say could be used as an alternative to antibiotics, has been shown to be effective in fighting Clostridium difficile in laboratory mice.

Featured Articles